What happened
Pulmuone Corporate updated its previously filed a subsidiary's consolidated results for FY2025: revenue of US$636M (+11.57% year on year), operating profit of US$23.2M (+31.34% year on year) and net income of US$4.38M (from a loss a year earlier).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$636M |
|---|---|
| Revenue vs a year earlier | +11.57% |
| Operating profit | US$23.2M |
| Net income | US$4.38M |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-03, [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary) |
| Source | DART rcept 20260203800416 → open original filing |
Source: DART. Information only, not investment advice.